Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas

NCT04390802 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04390802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04390802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2021
Completion date
December 31, 2021
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pituitary adenoma